Stefan Utzolino

Stefan Utzolino

Auto-generated profile, based on publicly available information

Stefan Utzolino

Department of General and Visceral Surgery, Center for Surgery, Medical Center University of Freiburg, Hugstetterstraße 55, 79106 Freiburg, Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2018 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
JMJohanna Müssig
Johanna Müssig
ANAmir M. Nia
Amir M. Nia
MMMaryna Masyuk
Maryna Masyuk
ALAlexander Lauten
Alexander Lauten
ASAnne Lena Sacher
Anne Lena Sacher
CJChristian Jung
Christian Jung
In intensive care units (ICU) octogenarians become a routine patients group with aggravated therapeutic and diagnostic decision-making. Due to increased mortality and a reduced quality of life in this high-risk population, medical decision-making a fortiori requires an optimum of risk stratification. Recently, the VIP-1 trial prospectively observed that the clinical frailty scale (CFS) performed well in ICU patients in overall-survival and short-term outcome prediction. However, it is known that healthcare systems differ in the 21 countries contributing to the VIP-1 trial. Hence, our main focus was to investigate whether the CFS is usable for risk stratification in octogenarians admitted to diversified and high tech German ICUs. This multicentre prospective cohort study analyses very old patients admitted to 20 German ICUs as a sub-analysis of the VIP-1 trial. Three hundred and eight patients of 80 years of age or older admitted consecutively to participating ICUs. CFS, cause of admission, APACHE II, SAPS II and SOFA scores, use of ICU resources and ICU- and 30-day mortality were recorded. Multivariate logistic regression analysis was used to identify factors associated with 30-day mortality. Patients had a median age of 84 [IQR 82–87] years and a mean CFS of 4.75 (± 1.6 standard-deviation) points. More than half of the patients (53.6%) were classified as frail (CFS ≥ 5). ICU-mortality was 17.3% and 30-day mortality was 31.2%. The cause of admission (planned vs. unplanned), (OR 5.74) and the CFS (OR 1.44 per point increase) were independent predictors of 30-day survival. The CFS is an easy determinable valuable tool for prediction of 30-day ICU survival in octogenarians, thus, it may facilitate decision-making for intensive care givers in Germany. The VIP-1 study was retrospectively registered on ClinicalTrials.gov (ID: NCT03134807 ) on May 1, 2017.

1 September 2010 in Journal of Critical Care
Verified
Journal Article
Closed access
SUStefan Utzolino
Stefan Utzolino
MKMagnus Kaffarnik
Magnus Kaffarnik
TKTobias Keck
Tobias Keck
MBMeike Berlet
Meike Berlet
UHUlrich Theodor Hopt
Ulrich Theodor Hopt

1 October 2014 in Journal of Critical Care
Verified
Journal Article
Closed access
SUStefan Utzolino
Stefan Utzolino
CDChristian M. Ditzel
Christian M. Ditzel
PBPeter K. Baier
Peter K. Baier
UHUlrich T. Hopt
Ulrich T. Hopt
MKMagnus F. Kaffarnik
Magnus F. Kaffarnik

5 November 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KOKlementina Ocskay
Klementina Ocskay
DTDana Tomescu
Dana Tomescu
AFAndreas Faltlhauser
Andreas Faltlhauser
DJDavid Jacob
David Jacob
SFSigrun Friesecke
Sigrun Friesecke
ZMZsolt Molnar
Zsolt Molnar
Background: Our aim is to report the results of the ‘liver indication’ subset of patients in the CytoSorb International Registry. Methods: Structured data were recorded. Treatment characteristics and changes from T1 (start of hemoadsorption) to T2 (termination) were evaluated with a special focus on bilirubin, C-reactive protein, procalcitonin, interleukin-6, platelet levels, SOFA scores, mortality, and subjective assessment by the attending physicians. Results: Until January 2021, from the total 1434 patients, 109 (age: 49.2 ± 17.1 years, 57.8% males) received treatment for hyperbilirubinemia. APACHE II-predicted mortality was 49.6 ± 26.8%. In the study, 91% of patients were alive at the termination of hemoadsorption and improvement was observed by the physicians in 75 cases. Overall, 65 (59.6%) patients died in the hospital, and 60 (55.0%) died in the ICU. Patients received a median of two treatments for a median of 43 h (interquartile range: 24–72 h) in total. Serum bilirubin levels reduced significantly to −4.6 (95% CI: −6.329 to −2.8) mg/dL. Thrombocytopenia was reported in four patients as an adverse event. Conclusions: We report the largest case series on hemoadsorption for ‘liver indication’ from the CytoSorb International Registry. The finding of significant bilirubin removal observed in our study could have substantial impact in designing and executing further studies on the effects of hemoadsorption in liver dysfunction, which are certainly warranted.

18 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
HGHanna Goelz
Hanna Goelz
Simon WetzelSimon Wetzel
Simon Wetzel
NMNegin Mehrbarzin
Negin Mehrbarzin
SUStefan Utzolino
Stefan Utzolino
GHGeorg Häcker
Georg Häcker
Mohamed Tarek BadrMohamed Tarek Badr
Mohamed Tarek Badr
Objectives: Infections of the ascitic fluid are serious conditions that require rapid diagnosis and treatment. Ascites is often accompanied by other critical pathologies such as gastrointestinal bleeding and bowel perforation, and infection increases the risk of mortality in intensive care patients. Owing to a relatively low success rate of conventional culture methods in identifying the responsible pathogens, new methods may be helpful to guide antimicrobial therapy and to refine empirical regimens. Here, we aim to assess outcomes and to identify responsible pathogens in ascitic fluid infections, in order to improve patients’ care and to guide empirical therapy. Methods: Between October 2019 and March 2021, we prospectively collected 50 ascitic fluid samples from ICU patients with suspected infection. Beside standard culture-based microbiology methods, excess fluid underwent DNA isolation and was analyzed by next- and third-generation sequencing (NGS) methods. Results: NGS-based methods had higher sensitivity in detecting additional pathogenic bacteria such as E. faecalis and Klebsiella in 33 out of 50 (66%) ascitic fluid samples compared with culture-based methods (26%). Anaerobic bacteria were especially identified by sequencing-based methods in 28 samples (56%), in comparison with only three samples in culture. Analysis of clinical data showed a correlation between sequencing results and various clinical parameters such as peritonitis and hospitalization outcomes. Conclusions: Our results show that, in ascitic fluid infections, NGS-based methods have a higher sensitivity for the identification of clinically relevant pathogens than standard microbiological culture diagnostics, especially in detecting hard-to-culture anaerobic bacteria. Patients with such infections may benefit from the use of NGS methods by the possibility of earlier and better targeted antimicrobial therapy, which has the potential to lower the high morbidity and mortality in critically ill patients with ascitic bacterial infection.

15 November 2007 in Leukemia
Verified
Journal Article
Closed access
CKChristian Kratz
Christian Kratz
CNCharlotte Marie Niemeyer
Charlotte Marie Niemeyer
EJE Jüttner
E Jüttner
MKM Kartal
M Kartal
AWA Weninger
A Weninger
KWKatharina Wimmer
Katharina Wimmer